Title |
Clinical review: The management of hypertensive crises
|
---|---|
Published in |
Critical Care, July 2003
|
DOI | 10.1186/cc2351 |
Pubmed ID | |
Authors |
Joseph Varon, Paul E Marik |
Abstract |
Hypertension is an extremely common clinical problem, affecting approximately 50 million people in the USA and approximately 1 billion individuals worldwide. Approximately 1% of these patients will develop acute elevations in blood pressure at some point in their lifetime. A number of terms have been applied to severe hypertension, including hypertensive crises, emergencies, and urgencies. By definition, acute elevations in blood pressure that are associated with end-organ damage are called hypertensive crises. Immediate reduction in blood pressure is required only in patients with acute end-organ damage. This article reviews current concepts, and common misconceptions and pitfalls in the diagnosis and management of patients with acutely elevated blood pressure. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | <1% |
Canada | 2 | <1% |
Chile | 1 | <1% |
Italy | 1 | <1% |
Germany | 1 | <1% |
Colombia | 1 | <1% |
Brazil | 1 | <1% |
Greece | 1 | <1% |
Japan | 1 | <1% |
Other | 0 | 0% |
Unknown | 200 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 37 | 18% |
Student > Postgraduate | 34 | 16% |
Other | 26 | 12% |
Student > Master | 20 | 9% |
Researcher | 15 | 7% |
Other | 49 | 23% |
Unknown | 30 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 137 | 65% |
Agricultural and Biological Sciences | 13 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 10 | 5% |
Nursing and Health Professions | 7 | 3% |
Biochemistry, Genetics and Molecular Biology | 3 | 1% |
Other | 8 | 4% |
Unknown | 33 | 16% |